share_log

Avenue Therapeutics | UPLOAD: Others

SEC announcement ·  Jan 30 00:45
Summary by Futu AI
Avenue Therapeutics, a pharmaceutical company, has been informed by the Division of Corporation Finance Office of Life Sciences that the United States Securities and Exchange Commission (SEC) will not review its Registration Statement on Form S-3, which was filed on January 24, 2024. The SEC's communication, dated January 29, 2024, was addressed to Alix MacLean, CEO of Avenue Therapeutics, and highlighted that the responsibility for the accuracy and adequacy of disclosures lies with the company and its management. The SEC also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Avenue Therapeutics has been directed to contact Tamika Sheppard at the SEC with any further questions.
Avenue Therapeutics, a pharmaceutical company, has been informed by the Division of Corporation Finance Office of Life Sciences that the United States Securities and Exchange Commission (SEC) will not review its Registration Statement on Form S-3, which was filed on January 24, 2024. The SEC's communication, dated January 29, 2024, was addressed to Alix MacLean, CEO of Avenue Therapeutics, and highlighted that the responsibility for the accuracy and adequacy of disclosures lies with the company and its management. The SEC also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Avenue Therapeutics has been directed to contact Tamika Sheppard at the SEC with any further questions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.